← All trials
NCT03527745
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 30, 2018
- Primary completion
- Apr 30, 2019
- Completion date
- Apr 30, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 1040
- Arms / groups
- 5 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of BaselLead sponsor
- University of BaselSponsor investigator
- Centre Suisse de Recherches Scientifiques en Côte d'Ivoire (CSRS)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.